Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone
- 1 February 1979
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 19 (2) , 197-206
- https://doi.org/10.1016/s0010-7824(79)80032-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrelContraception, 1976
- Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in womenContraception, 1975
- Contraceptive effectiveness of silastic: Implants containing the progestin R-2323Contraception, 1975
- Long-term contraception by steroid-releasing implants. II A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in womenContraception, 1975
- Plasma levels of norethindrone after I.M. injection of 200 mg norethindrone enanthateContraception, 1975
- A preliminary report on the contraceptive use of subdermal implants containing norethindroneContraception, 1974
- Radioimmunoassay of norethindrone: Peripheral plasma levels after oral administration to humans and rhesus monkeysContraception, 1974
- Fertility control in women with a progestogen released in microquantities from subcutaneous capsulesAmerican Journal of Obstetrics and Gynecology, 1969
- Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsulesAmerican Journal of Obstetrics and Gynecology, 1969
- The use of silicone rubber as a carrier for prolonged drug therapyJournal of Surgical Research, 1964